OMNY Health AI Platform
Published on
8 min read

OMNY Health’s AI Platform Set to Improve Health Tech Collaborations

US-based healthtech company, OMNY Health, has unveiled a new AI-powered data platform. OMNY Health is a top healthcare ecosystem that facilitates cross-industry data sharing. The new OMNY Health AI platform is designed to support healthtech companies in a way that democratizes healthcare data.

According to BusinessWire, ArisGlobal and QuantHealth are already using the new platform to advance their AI-driven needs.

Improving Clinical Trials

QuantHealth is leveraging AI to improve timelines for clinical timelines and mitigate risks associated with trials. The company also uses the technology to identify populations that are likely to respond well to treatment. As one of OMNY Health AI companies, QuantHealth has trained its AI solution on a dataset of 350 million patients.

OMNY Health’s partnership will enable QuantHealth’s partners to expedite drug development by simulating clinical trials. The pharmaceutical partners will also utilize OMNY Health’s AI platform to use real-world evidence in clinical trial outcome prediction, patient responses and drug efficacy.

“Biotech is entering a vibrant part of life sciences history. This partnership furthers our commitment to quality data and access for our life sciences partners. By integrating diverse EHRs into organized, de-identified research data products, we can address disparities in clinical trials and close significant demographic information gaps in drug discovery and development,” QuantHealth VP for Clinical Data Science and Head of R&D Operations, Omri Matalon said.

Better Signal Detection

Another company that OMNY Health is collaborating with is ArisGlobal. This is a leading health tech company in pharmacovigilance, reporting systems, and safety monitoring. OMNY Health’s collaboration with this company will revolutionize the validation of safety signals and open the way for proactive signal detection.

Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal said, “Up to 95% of adverse event cases go unreported today, while processing ICSRs can be time-consuming, and analysis of medical literature and online forums is slow and inefficient. Combining LifeSphere products with comprehensive real-time RWD addresses these challenges head-on. By leveraging advanced technology and insights from extensive RWD, we are reshaping drug discovery and development.”

Networking in Healthcare

OMNY Health data platform will address the need for generative AI in de-identifying large structured and unstructured health record data sets. The platform will fix this problem across diverse patient populations and providers.

OMNY Health CEO, Mitesh Rao said, “Our mission is to free data from silos, allowing it to be shared, analyzed, and morphed into life-saving treatments and better care for patients. Life science organizations and providers often struggle with time and budget constraints that hinder their ability to learn from their data. Our work powering AI-driven platforms can unblock this process by partnering with AI developers with data and tools to accelerate breakthrough therapies and monitor new therapies for safety signals to ensure patient populations remain safe.”

For OMNY Health, the platform will provide data rails and infrastructures for health tech organizations. This will facilitate collaboration between health tech companies. The OMNY Health AI platform will also drive development and promote effective utilization of AI solutions to advance healthcare.

Diane Hicks
Scroll to Top